Related references
Note: Only part of the references are listed.Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
Phillip D. Monk et al.
LANCET RESPIRATORY MEDICINE (2021)
Coronavirus infections and immune responses
Geng Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Covid-19-Navigating the Uncharted
Anthony S. Fauci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
Yixuan J. Hou et al.
CELL (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
Carly G. K. Ziegler et al.
CELL (2020)
Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients
Pierre Bost et al.
CELL (2020)
Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients
Zhuo Zhou et al.
CELL HOST & MICROBE (2020)
Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19
Annsea Park et al.
CELL HOST & MICROBE (2020)
Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19
Hin Chu et al.
CLINICAL INFECTIOUS DISEASES (2020)
Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract
Joan C. Smith et al.
DEVELOPMENTAL CELL (2020)
Immunology of COVID-19: Current State of the Science
Nicolas Vabret et al.
IMMUNITY (2020)
Type I IFN immunoprofiling in COVID-19 patients
Sophie Trouillet-Assant et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors
Matthew Hackbart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
Interferon-α2b Treatment for COVID-19
Qiong Zhou et al.
FRONTIERS IN IMMUNOLOGY (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
Wen Wen et al.
CELL DISCOVERY (2020)
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Mingfeng Liao et al.
NATURE MEDICINE (2020)
Antiviral activities of type I interferons to SARS-CoV-2 infection
Emily Mantlo et al.
ANTIVIRAL RESEARCH (2020)
Type 1 interferons as a potential treatment against COVID-19
Erwan Sallard et al.
ANTIVIRAL RESEARCH (2020)
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients
Nan Wang et al.
CELL HOST & MICROBE (2020)
SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70
He-wei Jiang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients
Linnan Zhu et al.
IMMUNITY (2020)
Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
Jeong Seok Lee et al.
SCIENCE IMMUNOLOGY (2020)
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
Benjamin Israelow et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Lucas et al.
NATURE (2020)
COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis
Robert Lorenz Chua et al.
NATURE BIOTECHNOLOGY (2020)
A single-cell atlas of the peripheral immune response in patients with severe COVID-19
Aaron J. Wilk et al.
NATURE MEDICINE (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
Matthias Thoms et al.
SCIENCE (2020)
Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
Jack Major et al.
SCIENCE (2020)
Type III interferons disrupt the lung epithelial barrier upon viral recognition
Achille Broggi et al.
SCIENCE (2020)
Activation and evasion of type I interferon responses by SARS-CoV-2
Xiaobo Lei et al.
NATURE COMMUNICATIONS (2020)
Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells
Megan L. Stanifer et al.
CELL REPORTS (2020)
Interplay between SARS-CoV-2 and the type I interferon response
Margarida Sa Ribero et al.
PLOS PATHOGENS (2020)
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
Kumari G. Lokugamage et al.
JOURNAL OF VIROLOGY (2020)
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
Kenneth H. Dinnon et al.
NATURE (2020)
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Prabhu S. Arunachalam et al.
SCIENCE (2020)
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2
Idoia Busnadiego et al.
MBIO (2020)
Two distinct immunopathological profiles in autopsy lungs of COVID-19
Ronny Nienhold et al.
NATURE COMMUNICATIONS (2020)
SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant
Yoriyuki Konno et al.
CELL REPORTS (2020)
SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2
Jingfang Mu et al.
CELL DISCOVERY (2020)
Shared and Distinct Functions of Type I and Type III Interferons
Helen M. Lazear et al.
IMMUNITY (2019)
Decoding type I and III interferon signalling during viral infection
Emily Mesev et al.
NATURE MICROBIOLOGY (2019)
Human Coronavirus: Host-Pathogen Interaction
To Sing Fung et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 73 (2019)
Interferon-Stimulated Genes: What Do They All Do?
John W. Schoggins
ANNUAL REVIEW OF VIROLOGY, VOL 6, 2019 (2019)
Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections
Tessa Nelemans et al.
VIRUSES-BASEL (2019)
Type III IFNs: Beyond antiviral protection
Kotenko Sergei et al.
SEMINARS IN IMMUNOLOGY (2019)
Type III Interferons in Antiviral Defenses at Barrier Surfaces
Alexandra I. Wells et al.
TRENDS IN IMMUNOLOGY (2018)
Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness
Ioanna E. Galani et al.
IMMUNITY (2017)
Type III IFNs Are Commonly Induced by Bacteria-Sensing TLRs and Reinforce Epithelial Barriers during Infection
Charlotte Odendall et al.
JOURNAL OF IMMUNOLOGY (2017)
Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages
Xufang Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation
Sung Ho Park et al.
NATURE IMMUNOLOGY (2017)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection
Eu Suk Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
Helen M. Lazear et al.
IMMUNITY (2015)
High Secretion of Interferons by Human Plasmacytoid Dendritic Cells upon Recognition of Middle East Respiratory Syndrome Coronavirus
Vivian A. Scheuplein et al.
JOURNAL OF VIROLOGY (2015)
Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness
Pil Soo Sung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mechanisms of innate immune evasion in re-emerging RNA viruses
Daphne Y. Ma et al.
CURRENT OPINION IN VIROLOGY (2015)
Interferon-Stimulated Genes: A Complex Web of Host Defenses
William M. Schneider et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
To sense or not to sense viral RNA - essentials of coronavirus innate immune evasion
Eveline Kindler et al.
CURRENT OPINION IN MICROBIOLOGY (2014)
SARS-Coronavirus Open Reading Frame-9b Suppresses Innate Immunity by Targeting Mitochondria and the MAVS/TRAF3/TRAF6 Signalosome
Chong-Shan Shi et al.
JOURNAL OF IMMUNOLOGY (2014)
Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses
Vineet D. Menachery et al.
MBIO (2014)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment
Adriaan H. de Wilde et al.
JOURNAL OF GENERAL VIROLOGY (2013)
A Virological View of Innate Immune Recognition
Akiko Iwasaki
ANNUAL REVIEW OF MICROBIOLOGY, VOL 66 (2012)
Severe Acute Respiratory Syndrome Coronavirus Protein nsp1 Is a Novel Eukaryotic Translation Inhibitor That Represses Multiple Steps of Translation Initiation
Kumari G. Lokugamage et al.
JOURNAL OF VIROLOGY (2012)
Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages
Sung Ho Park et al.
NATURE IMMUNOLOGY (2011)
Lambda Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal Tracts Resistant to Viral Infections
Markus Mordstein et al.
JOURNAL OF VIROLOGY (2010)
Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus Infection
Tomoki Yoshikawa et al.
PLOS ONE (2010)
In Vitro Reconstitution of SARS-Coronavirus mRNA Cap Methylation
Mickael Bouvet et al.
PLOS PATHOGENS (2010)
Molecular Determinants for Subcellular Localization of the Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame 3b Protein
Eric C. Freundt et al.
JOURNAL OF VIROLOGY (2009)
Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase
Yu Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells
Krishna Narayananj et al.
JOURNAL OF VIROLOGY (2008)
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta
Jonathan C. Kagan et al.
NATURE IMMUNOLOGY (2008)
SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum
Kevin Knoops et al.
PLOS BIOLOGY (2008)
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome
Mark J. Cameron et al.
JOURNAL OF VIROLOGY (2007)
The intracellular sites of early replication and budding of SARS-coronavirus
Silke Stertz et al.
VIROLOGY (2007)
Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon
Luisa Cervantes-Barragan et al.
BLOOD (2007)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome
R Reghunathan et al.
BMC IMMUNOLOGY (2005)
Severe acute respiratory syndrome related coronavirus is inhibited by interferon-α
U Ströher et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Interferon-β 1a and SARS coronavirus replication
LE Hensley et al.
EMERGING INFECTIOUS DISEASES (2004)
Multiple enzymatic activities associated with Severe acute respiratory syndrome coronavirus helicase
KA Ivanov et al.
JOURNAL OF VIROLOGY (2004)
Treatment of SARS with human interferons
J Cinatl et al.
LANCET (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
EA Kurt-Jones et al.
NATURE IMMUNOLOGY (2000)